Sign in to confirm you’re not a bot
This helps protect our community. Learn more
Fireside Chat with Lexaria
8Likes
369Views
2022Jun 7
Fireside chat with Lexaria's CEO Chris Bunka and Senior Biotech Analyst John Vandermosten. We delve into a number of topics, both micro and macroeconomic. Crossing the blood brain barrier, long chain fatty acids, inflation, supply chain, other CBD approved products and big pharma. Chris also hints that some deals are in the works with national players around the globe. Other videos in the series: What is DehydraTECH?:    â€˘ What is DehydraTECH?   Lexaria's Work in Hypertension:    â€˘ Lexaria's Work in Hypertension   Lexaria's Nicotine Efforts:    â€˘ Lexaria's Nicotine Efforts  

Follow along using the transcript.

Unboxing Biotech

338 subscribers